Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561355 | PMC |
http://dx.doi.org/10.3389/fphar.2015.00180 | DOI Listing |
Annu Rev Pharmacol Toxicol
January 2025
Department of Pharmacology and Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; email:
G protein-coupled receptors (GPCRs) represent the largest family of plasma membrane proteins targeted for therapeutic development. For decades, GPCRs were investigated as monomeric entities during analysis of their pharmacology or signaling and during drug development. However, a considerable body of evidence now indicates that GPCRs function as dimers or higher-order oligomers.
View Article and Find Full Text PDFPharmacol Ther
November 2024
Institute of Pharmacology, Hannover Medical School, Hannover, Germany.
Inflammation-driven diseases encompass a wide array of pathological conditions characterised by immune system dysregulation leading to tissue damage and dysfunction. Among the myriad of mediators involved in the regulation of inflammation, histamine has emerged as a key modulatory player. Histamine elicits its actions through four rhodopsin-like G-protein-coupled receptors (GPCRs), named chronologically in order of discovery as histamine H, H, H and H receptors (HR).
View Article and Find Full Text PDFSci Rep
August 2024
Faculty of Science and Technology, University of Silesia in Katowice, Będzińska 39, 41-205, Sosnowiec, Poland.
Burrowed discontinuity surfaces associated with condensed fossil concentrations demarcate breaks (hiatuses) in the Phanerozoic marine sedimentary record. Such intervals may be difficult to interpret in view of complex anatomy and varied fossil signatures. Transformation of a discontinuity surface into a heavily burrowed 'pseudobreccia' may further complicate the record, but this issue has remained unexploited to date.
View Article and Find Full Text PDFACS Infect Dis
October 2024
Centre for Superbug Solutions and ARC Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4072, Australia.
There is a lack of new antibiotics to combat drug-resistant bacterial infections that increasingly threaten global health. The current pipeline of clinical-stage antimicrobials is primarily populated by "new and improved" versions of existing antibiotic classes, supplemented by several novel chemical scaffolds that act on traditional targets. The lack of fresh chemotypes acting on previously unexploited targets (the "holy grail" for new antimicrobials due to their scarcity) is particularly unfortunate as these offer the greatest opportunity for innovative breakthroughs to overcome existing resistance.
View Article and Find Full Text PDFCancer Metastasis Rev
December 2024
Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Bergen University, Bergen, Norway.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!